News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Dallas Matthew D
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/05/2019 |
4
| Dallas Matthew D (Director) has filed a Form 4 on Biostage, Inc.
Txns:
| Granted 10,364 options to buy
@ $2.9, valued at
$30.1k
Granted 8,411 options to buy
@ $2.9, valued at
$24.4k
|
|
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2018 |
4
| Dallas Matthew D (Director) has filed a Form 4 on Biostage, Inc.
Txns:
| Granted 10,897 options to buy
@ $2.75, valued at
$30k
|
|
11/15/2018 |
3
| Dallas Matthew D (Director) has filed a Form 3 on Biostage, Inc. |
02/02/2018 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns:
| Granted 250,000 options to buy
@ $3.08, valued at
$770k
|
|
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/04/2017 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns:
| Sold 1,473 shares
@ $36.25, valued at
$53.4k
|
|
12/01/2016 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns:
| Sold 1,473 shares
@ $35.1671, valued at
$51.8k
|
|
03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|